Search results for " market"
Article
Biomanufacturing Outsourcing Globalization Continues
Contract manufacturing organizations (CMOs) in developing markets, however, are unlikely to threaten the powerhouse CMOs in the United States and Europe, according to preliminary data from BioPlan Ass…
Article
Healthcare Reform in China
An appealing market
The Chinese market is attractive to foreign investors for many reasons. It is the world’s third largest market for pharmaceuticals with annual sale of US$71 billion. In fact, i…
Article
Biopharma Advances Demand Specialized Expertise
The approval of the first biosimilar in the United States, as well as continuing consolidation in the biopharma and contract development and manufacturing markets, are just two indicators of the ongoi…
Article
Report from India
Adopting the market-based price mechanism, the policy is based on the simple average price for all brands with a market share above 1% in their segment.
According to industry sources, the new …
Article
Single-use Bioreactors Have Reached the Big Time
Rapid expansion of the single-use bioreactor market supports Adams’ statement. Market research firm Markets and Markets projects the US bioreactor market will increase at a compound annual growth rate…
Article
Modular Manufacturing Platforms for Biologics
According to Emel, speed to market is no longer the only business driver behind using modular systems; asset flexibility, cost of goods, and investment deferment are now key significant drivers of mod…
Article
EMA Collaborates with HTA Assessment Networks
Gaining access to Europe’s pharmaceutical markets has become a multi-stage operation. The licensing of a new drug is only a preliminary step in what can be a lengthy and complex procedure for some pha…
Article
Brazil Emerges as Global Biopharm Collaborator
The pharmaceutical market in Brazil has been growing steadily and strongly in the past five years. The country is eying production and innovation, relying on the key support of the government. Accordi…
Article
Managing Biomanufacturing Capacity Expectations
Some of these could include reports of a serious adverse event, slow enrollment in clinical trials, sale of a parent company that is developing the drug, an unusually successful marketing strategy, pr…
Article
Framing Biopharma Success in 2016
Peters
The US biopharmaceutical industry turned a new page in 2015 when FDA approved Zarxio (filgrastim-sndz), the first biosimilar approved for use in US markets, in March 2015. Biotechnology sto…